Compare Stocks: DGX vs. IDXX

Market Snapshot

Current market context for the selected companies.

DGX

$244.39

Market Cap —

Sector Healthcare

Industry Diagnostics

Data through 2026-08-21

IDXX

$556.93

Market Cap $43.88B

Sector Healthcare

Industry Diagnostics

Data through 2026-08-21

Performance

Absolute returns and relative performance versus SPY.

Metric	DGX	IDXX
1 Month	+7.2%	+3.3%
1 Month vs SPY	+3.5%	-0.5%
3 Months	+26.1%	+0.7%
3 Months vs SPY	+23.0%	-2.4%
6 Months	+20.7%	-12.4%
6 Months vs SPY	+9.7%	-23.5%
1 Year	+32.5%	-13.0%
1 Year vs SPY	+12.5%	-33.0%
2 Years	—	+13.1%
2 Years vs SPY	—	-25.0%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	DGX	IDXX
Revenue Growth	—	9.7%
Earnings Growth	—	17.6%
Gross Margin	—	62.4%
Operating Margin	—	35.0%
Net Margin	—	25.0%
Return on Equity	—	74.2%
Return on Assets	—	27.1%

Valuation

Common valuation multiples shown side by side.

Metric	DGX	IDXX
P / E	—	38.4
Forward P / E	—	33.3
P / S	—	9.4
P / B	—	26.7
EV / Sales	—	9.6
EV / EBIT	—	27.6
P / FCF	—	47.3
FCF Yield	—	2.1%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	DGX	IDXX
Free Cash Flow	—	$909.37M
Operating Cash Flow	—	$1.37B
Debt / Equity	—	68.0%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	DGX	IDXX
Next Earnings	—	2026-11-02
EPS Estimate	—	3.71
Revenue Estimate	—	1.19B
EPS Growth	—	+9.0%
Revenue Growth	—	+7.8%
Analyst Coverage	—	12